Ziarco
Canterbury
United Kingdom
9 articles about Ziarco
-
Pfizer-Backed Ziarco Exploring Sale, Deal Could Bring in $1 Billion+
6/15/2016
-
Ziarco Release: Appointment Of Dr. Arvind Hundal As Chief Business Officer
2/29/2016
-
Phase 2a Psoriasis Study Initiated With Ziarco's Lead Compound ZPL-389
2/2/2016
-
Ziarco Appoints Mike Grey As Executive Chairman Of Board Of Directors
7/20/2015
-
Ziarco Initiates Phase IIa Clinical Trial Of ZPL-389 In Atopic Dermatitis
6/10/2015
-
Ziarco Announces Appointment Of Mike Grey To Board Of Directors
12/4/2014
-
Ziarco Bags $33.1 Million
11/10/2014
-
Ziarco Secures £1.7M Grant From UK’s Technology Strategy Board To Support Phase 2a Of ZPL-389 In Atopic Dermatitis
6/18/2014
-
Dr. John LaMattina Joins Ziarco as Strategic Advisor
3/18/2013